SCHEMBL2494461

SCHEMBL2494461

Oc1ccccc1-c1cccc(CN2CCCCC2)c1-c1ccccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 2/20 0.53
KDM4E B2RXH2 4/20 0.51
HRH3 Q9Y5N1 1/20 0.51
ALDH1A1 P00352 3/20 0.49
ADORA2A P29274 3/20 0.48
ADORA1 P30542 3/20 0.48
POLB P06746 1/20 0.46
TSHR P16473 1/20 0.44
GFER P55789 1/20 0.44
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 1/20 0.43
MAPK1 P28482 1/20 0.43
BRD4 O60885 1/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
ALOX12 P18054 1/20 0.43
NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2493514 0.98 MPO (0.54) MPOKDM4EHRH3ALDH1A1ADORA2A
SCHEMBL2492302 0.85 MPO (0.50) MPOKDM4EHRH3ADORA2AADORA1
SCHEMBL7946364 0.80 MPO (0.81) MPOKDM4EHRH3ALDH1A1POLB
SCHEMBL2491547 0.79 ALDH1A1 (0.49) KDM4EHRH3ALDH1A1ADORA2AADORA1
SCHEMBL10415354 0.78 MPO (0.84) MPOKDM4EHRH3ALDH1A1TSHR
SCHEMBL2491500 0.77 KMT2A (0.49) KDM4EHRH3ALDH1A1ADORA2AADORA1
SCHEMBL22955908 0.75 CYP2C19 (0.55) MPOKDM4EHRH3ALDH1A1POLB
SCHEMBL2492921 0.75 MEN1 (0.59) KDM4EHRH3ALDH1A1TSHRMEN1
SCHEMBL10665335 0.74 KDM4E (0.70) MPOKDM4EHRH3ALDH1A1POLB
SCHEMBL11194277 0.74 ALDH1A1 (0.73) MPOKDM4EHRH3ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MPO 65/4885KDM4E 2772/4885HRH3 62/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MPO 117/4885KDM4E 3096/4885HRH3 34/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MPO 100/4885KDM4E 3125/4885HRH3 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.